Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1–uninfected adult participants in the US
Year: 2023
Type: article
Source: Vaccine
Authors: Hong-Van Tieu, Shelly Karuna, Yunda Huang, Magdalena E. Sobieszczyk, Hua Zheng, Georgia D. Tomaras, David C. Montefiori, Mingchao Shen, Stephen DeRosa, Kristen Cohen, Margaret Brewinski Isaacs, Stephanie Regenold, Jack Heptinstall, Kelly E. Seaton, Sheetal Sawant, Brianna Furch, Michael Pensiero, Lawrence Corey, Katharine J. Bar
Institutions: New York Blood Center, Columbia University Irving Medical Center, Fred Hutch Cancer Center, University of Washington, United States Department of Health and Human Services, Administration for Children and Families, Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Duke University, University of Pennsylvania
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: G1169301292, G1384187122, G1406424272, G2358037835, G35885623, G547379174, G5565402114, G7522203623, G7656363126, G819814859, HIV Vaccine Trials Network Laboratory Center, HIV Vaccines Clinical Trials Network Leadership and Operations Center, Columbia Collaborative HIV/AIDS Clinical Trials Unit
OpenAlex ID: W4386531383